Core Viewpoint - Oseltamivir remains the preferred choice among various new antiviral drugs for influenza in the 2025 flu season due to its affordability, broad applicability, authoritative recommendations, and strong supply availability [1]. Group 1: Market Position and Demand - In December 2025, pediatric clinics experienced long queues of parents seeking treatment for their children, with many doctors prescribing Oseltamivir [2]. - Despite the emergence of several new antiviral drugs, Oseltamivir continues to be the most commonly used medication for influenza treatment, thanks to its solid efficacy, low price, and wide accessibility [4]. - The demand for Oseltamivir surges every winter during flu season, as families face significant financial considerations when choosing medications [8]. Group 2: Economic and Accessibility Advantages - Oseltamivir is significantly cheaper than newer antiviral drugs, with a typical box costing only a few dozen yuan, while newer drugs can cost hundreds of yuan per treatment course [9]. - The economic efficiency of Oseltamivir is particularly beneficial during influenza pandemics, as it allows for broader treatment coverage without overwhelming healthcare budgets [9]. - Oseltamivir is a staple in major hospitals and is also available in county-level hospitals and community health centers, ensuring timely access for patients across different regions [9]. Group 3: Safety and Efficacy - Since its launch in 1999, Oseltamivir has demonstrated safety and efficacy through various influenza outbreaks, making it a reliable option for vulnerable populations [11]. - Oseltamivir is suitable for a wide range of patients, including children as young as two weeks old, pregnant women, and those with underlying health conditions, which enhances its appeal as a family treatment option [12]. - The drug's long-term safety data is particularly important for high-risk groups, as it has been shown to be effective and safe for use in these populations [12]. Group 4: Guidelines and Recommendations - Multiple expert consensus guidelines in China recommend Oseltamivir as a first-line treatment for influenza, especially for high-risk groups [14]. - The latest clinical practice guidelines emphasize Oseltamivir's role as the preferred medication for severe cases, children, and pregnant women, based on substantial clinical evidence [15][16]. Group 5: Brand Trust and Market Leadership - Eastsun Pharmaceutical is the largest global producer of Oseltamivir, with its products being widely recognized and trusted by both doctors and patients [21]. - The company has invested significantly in the quality management of Oseltamivir production, ensuring that its products meet high standards and are readily available across various distribution channels [22]. - Eastsun's commitment to quality and accessibility has established "Kewai" as a household name, making it a key player in ensuring sufficient supply during flu outbreaks [22].

Group 1 - The article discusses the increase in flu cases during the winter season and the appropriate medication for treatment [1] - It questions the effectiveness of combining cold medicine and fever reducers for a quicker recovery from the flu [1] - The article aims to clarify misconceptions regarding flu treatment measures [1]

Group 1 - The article emphasizes that combining cold medicine and antipyretics is not advisable as it can lead to increased drug dosage and potential liver and kidney damage [1][2] - Experts warn that some traditional Chinese medicines may contain Western drug components, which can also lead to overdosing and harm to liver and kidneys [2] - It is crucial for patients experiencing flu symptoms to avoid self-medication and seek medical attention promptly [3] Group 2 - For children with flu, it is important not to use fever reduction as a criterion for stopping medication, as this could lead to a relapse or other serious conditions like myocarditis or pneumonia [4] - Parents can assess the severity of their child's flu using the ABC method, which includes checking the child's vitality, breathing condition, and skin color [5] - The article highlights the recent surge in flu cases and advises against blind medication use, stressing the importance of timely medical consultation [6]

Core Viewpoint - The approval of SYH2085 by the National Medical Products Administration of China marks a significant advancement for the company in the development of innovative antiviral treatments for influenza [1] Group 1: Product Development - SYH2085 is a novel oral small molecule candidate drug developed by the company, designed to inhibit the RNA polymerase acidic protein (PA) endonuclease activity of influenza viruses [1] - The clinical indication approved is for the treatment of uncomplicated influenza A and B in adults and adolescents aged 12 and older [1] - Preclinical studies have demonstrated that SYH2085 exhibits clear, broad-spectrum, and excellent inhibitory effects against both influenza A and B viruses, effectively reducing viral load and flu-like symptoms in animal models [1] Group 2: Clinical and Market Potential - The drug shows promising pharmacokinetic properties and safety, indicating a high clinical development value [1] - The introduction of SYH2085 is expected to enhance the company's product pipeline in the field of anti-infective treatments [1]

Core Viewpoint - The current flu season in China is experiencing a high prevalence, with a positive detection rate of 54.2% for flu viruses in outpatient and emergency departments from December 1 to 7, indicating an upward trend in flu virus detection, although the rate of increase is slowing down [1] Group 1: Flu Characteristics and Treatment - Flu symptoms are more severe than those of a common cold, including sudden high fever (over 39 degrees Celsius), chills, headaches, muscle aches, and fatigue, which can lead to serious complications in vulnerable populations such as the elderly and those with underlying health conditions [2] - Flu is generally self-limiting, with mild cases recovering at home through rest and proper nutrition; however, severe cases may require antiviral treatment and management of complications [2][3] Group 2: Vaccination Recommendations - Vaccination is the most effective and economical means of preventing infectious diseases; individuals, especially children, the elderly, and those with underlying conditions, are encouraged to get vaccinated as flu activity increases [4] - Vaccination guidelines specify that children aged 6 months to 8 years require two doses of inactivated vaccine for their first vaccination, while those aged 9 and above need only one dose annually, regardless of previous vaccinations [5] Group 3: Post-Recovery Guidelines - After recovering from flu, individuals should maintain good hygiene practices, such as wearing masks, frequent handwashing, and ensuring proper ventilation to prevent reinfection [6][7] - Vulnerable groups should take extra precautions in crowded places, and schools should monitor health conditions to prevent the spread of illness [7]

Core Viewpoint - The current flu season in China is experiencing a high prevalence, with a positive detection rate of 54.2% for flu viruses in outpatient and emergency departments from December 1 to 7, indicating an upward trend in flu virus detection, although the rate of increase is slowing down [1] Group 1: Flu vs. Common Cold - The pathogens detected in China are common known pathogens, with no new infectious diseases reported [2] - Flu symptoms are more severe, characterized by sudden high fever (over 39 degrees Celsius), chills, headaches, muscle aches, and fatigue, potentially leading to serious complications in vulnerable populations [2] - Common colds are generally caused by rhinoviruses and parainfluenza viruses, with milder symptoms and typically self-resolving within a week [2] Group 2: Treatment and Prevention - Flu is generally self-limiting, with mild cases recovering at home; however, severe cases may require antiviral treatment as per the national guidelines [2][3] - Vaccination is the most effective and economical means of preventing infectious diseases, especially for high-risk groups such as children, the elderly, and those with underlying health conditions [4] - Vaccination can significantly reduce the risk of contracting flu and developing severe cases, even if some vaccinated individuals still contract the virus [4] Group 3: Vaccination Guidelines - Children aged 6 months to 8 years require two doses of inactivated vaccine for their first vaccination, while those previously vaccinated need only one dose [5] - For individuals aged 9 and above, only one dose is required annually, regardless of previous vaccinations [5] - Vaccination is necessary each flu season due to the virus's tendency to mutate and the waning immunity from previous vaccinations [5] Group 4: Post-Recovery Care - After recovery, individuals should maintain good hygiene practices, such as wearing masks, frequent handwashing, and ensuring proper ventilation [6][7] - It is advised that flu patients stay in separate rooms to minimize contact with others, and common surfaces should be disinfected regularly [7] - Vulnerable populations should take extra precautions in crowded places, and schools should monitor health conditions to prevent disease spread [7]

Core Viewpoint - The article provides recommendations for traditional Chinese medicine (TCM) methods to help alleviate flu symptoms and reduce infection risks during the flu season. Treatment and Prevention - A preventive formula is suggested for high-risk groups, focusing on enhancing immunity and preemptively combating the flu virus. The formula includes 10 grams each of raw astragalus, daqingye, and eleutherococcus, to be taken as a decoction twice daily [3]. - The components of the formula are explained: raw astragalus boosts immunity, daqingye has heat-clearing and detoxifying properties, and eleutherococcus strengthens energy and supports the body's defenses [3]. External Treatment Methods - External treatment methods are recommended for symptom relief, especially for those who find it difficult to take medicine or have mild symptoms. Techniques include guasha along the "governing vessel" on the back and cupping therapy [4]. - Specific scenarios for these methods include high fever (above 38.5°C) and severe throat pain, with instructions on how to perform these techniques safely [4][5]. Pediatric Care - Gentle external treatment methods are highlighted for children, emphasizing safety and effectiveness. Techniques include pediatric massage to reduce fever, clear phlegm, and relieve nasal congestion [6]. - Specific massage techniques are outlined, such as pushing from the center of the forehead to the hairline and massaging around the ears and temples [6][7]. Expert Contributions - The article features insights from experts in traditional Chinese medicine, including directors from affiliated hospitals, emphasizing the safety and efficacy of these methods for flu management [8].

Core Insights - Beijing has entered the influenza epidemic period earlier than usual, with the peak possibly already reached, as respiratory diseases account for 35%-40% of total daily consultations at the Capital Institute of Pediatrics [1][3][4] Group 1: Current Situation - The flu activity in Beijing has been increasing since late October, entering the epidemic phase by mid-November, approximately four weeks earlier than last year [3] - The daily consultation volume for respiratory diseases at the Capital Institute of Pediatrics reached this year's peak in the last two weeks, although it is slightly lower than previous years' peaks [4] Group 2: Measures Taken - To manage the winter surge in patient visits, the institute has increased personnel and appointment availability in respiratory, internal medicine, and fever clinics [4] - New online services have been introduced, including "external hospital follow-up" and dual appointment options for online and offline consultations, allowing for more efficient patient management [5] Group 3: Expert Insights - The resistance rate to Oseltamivir (Tamiflu) is currently between 1% and 2%, indicating that it remains effective against influenza [7] - It is crucial for children showing symptoms of influenza to receive antiviral treatment within 48 hours of onset to reduce the risk of severe illness [8]

Core Points - The article provides a comprehensive guide on flu prevention and management during the flu season, emphasizing the importance of vaccination and proper treatment methods [1] Group 1: Flu Diagnosis and Symptoms - Influenza is primarily caused by type A and B flu viruses, with common symptoms including fever above 38°C, headaches, muscle aches, and fatigue [3] - Diagnosis can be confirmed through throat swab tests for flu virus antigens or nucleic acids, which typically take 15 minutes to 1 hour [3] Group 2: Treatment Recommendations - Antiviral medications should be taken within 48 hours of symptom onset for effective treatment, while antibiotics are ineffective against viral infections [3] - Overuse of antipyretics to control symptoms is discouraged, especially in vulnerable populations such as the elderly and infants [4] Group 3: Emergency Situations - High-risk individuals should seek immediate medical attention if they experience persistent high fever, excessive phlegm, difficulty breathing, or severe symptoms [4] Group 4: Vaccination Importance - Vaccination remains one of the most effective and economical methods for flu prevention, even for those who have previously contracted the flu [5] - Different flu virus subtypes may circulate in a single season, and vaccination can provide protection against multiple strains [5]

Core Points - The article discusses the rising incidence of influenza and respiratory infectious diseases, highlighting a significant increase in sales of flu test kits and antiviral medications on various e-commerce platforms [2]. Group 1: Influenza Overview - Influenza is primarily caused by type A and B influenza viruses, with common clinical symptoms including fever above 38°C, headaches, muscle aches, and fatigue [5]. - Diagnosis can be made through throat swab tests for influenza virus antigens or nucleic acids, typically completed within 15 minutes to 1 hour [5]. Group 2: Treatment Recommendations - Antiviral medications should be taken within 48 hours of symptom onset for effective treatment, while antibiotics are ineffective against viral infections [5]. - Caution is advised against excessive use of antipyretics, especially combining different medications with the same active ingredients, to avoid adverse drug reactions [6]. Group 3: High-Risk Groups - High-risk populations, such as the elderly and young children, should seek immediate medical attention if experiencing severe symptoms like persistent high fever, excessive phlegm, or difficulty breathing [6][7]. Group 4: Vaccination Guidance - Vaccination remains one of the most effective and economical methods to prevent influenza, even for those who have previously contracted the virus [8]. - Different influenza virus subtypes may circulate in a single season, and vaccination can provide protection against other subtypes not previously encountered [8].